Insider Transactions in Q3 2022 at Verrica Pharmaceuticals Inc. (VRCA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 11
2022
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
BUY
Open market or private purchase
|
Direct |
7,500
+32.31%
|
$22,500
$3.4 P/Share
|
|
Jul 05
2022
|
Ted White PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
23,809
+44.69%
|
$47,618
$2.1 P/Share
|
|
Jul 05
2022
|
John A Stalfort Iii Director |
BUY
Open market or private purchase
|
Direct |
238,095
+25.38%
|
$476,190
$2.1 P/Share
|
|
Jul 05
2022
|
Paul B Manning |
BUY
Open market or private purchase
|
Direct |
4,761,904
+25.86%
|
$9,523,808
$2.1 P/Share
|
|
Jul 05
2022
|
Christopher G. Hayes CHIEF LEGAL OFFICER |
BUY
Open market or private purchase
|
Direct |
5,714
+41.03%
|
$11,428
$2.1 P/Share
|
|
Jul 05
2022
|
Gary Goldenberg Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
23,809
+50.0%
|
$47,618
$2.1 P/Share
|
|
Jul 05
2022
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,428,571
+22.09%
|
$2,857,142
$2.1 P/Share
|